Pharma & Biotech

A prominent financial publication's recent endorsement has refocused investor attention on Viking Therapeutics and its potential trajectory through 2026. The...

Shares of ophthalmic medical technology company Glaukos are receiving conflicting cues from the market. While prominent Wall Street analysts are...

While BioNTech stock trades near its 52-week low, a significant shift is occurring behind the scenes. Prominent institutional investors are...

For remaining investors in CureVac, the clock is ticking down to a decisive moment. The company's journey as an independent...

Immunovant Inc. has received a significant financial boost, with its shares trading notably higher following the successful completion of a...

The outlook for UnitedHealth Group is becoming increasingly complex as the healthcare giant contends with dual challenges: a significant new...

Shares of Comfort Systems USA are approaching a potentially pivotal moment, driven by two distinct but concurrent developments. Market attention...

Tilray Brands, Inc. saw its share price skyrocket in pre-market trading Friday, recording gains between 27% and 30%. The stock,...

The fate of CureVac's independent stock market journey has been sealed. BioNTech has successfully cleared the final hurdle for its...

Veru Inc. has officially scheduled the release of its 2025 financial results. The report will be issued on Wednesday, December...